Endocrine Testing Market Size - Growth, Share by 2031
The Endocrine Testing Market is expected to register a CAGR of 8.3% from 2023 to 2031, with a market size expanding from US$ XX Million in 2023 to US$ XX Million by 2031.
The Endocrine Testing Market report covers analysis By Test (Thyroid, Insulin, Follicle Stimulating Hormone, Estradiol, Testosterone, Luteinizing Hormone, Progesterone, DHEA-S, Prolactin, Human Chorionic Gonadotropin, Cortisol and Others); Technology (Immunoassay, Tandem Mass Spectrometry, Monoclonal and Polyclonal Antibody, Sensor Technology, Clinical Chemistry and others); End User (Hospitals, Diagnostic Laboratory and Others. The global analysis is further broken down at the regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Endocrine Testing Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Endocrine Testing Market Segmentation
Test- Thyroid
- Insulin
- Follicle Stimulating Hormone
- Estradiol
- Testosterone
- Luteinizing Hormone
- Progesterone
- DHEA-S
- Prolactin
- Human Chorionic Gonadotropin
- Cortisol and Others
- Immunoassay
- Tandem Mass Spectrometry
- Monoclonal and Polyclonal Antibody
- Sensor Technology
- Clinical Chemistry and others
- Hospitals
- Diagnostic Laboratory and Others
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Endocrine Testing Market Growth Drivers- Endocrine disorder prevalence boosts market: The rising prevalence of disorders related to endocrine glands, such as diabetes, thyroid diseases, and adrenal disorders, fuels the growth in the size of the endocrine testing market. It is reported that with increased awareness, early and accurate testing becomes necessary. The constant demand for effective diagnosis and management tools, through the reports of market analysis, has continued to drive the growth of the global market while competitive analysis identifies endocrine testing as the requisite for managing these chronic health issues.
- High-sensitivity immunoassays, POC devices drive growth: These include high-sensitivity immunoassays and point-of-care devices. New technologies enhance the accuracy of tests and reduce their turnaround time, thus meeting the growing demand for quick and reliable testing. The market trend shows that continuous research and development boosts the growth of the market. Competitive analysis indicates that high-value tests are increasing. Based on the PEST analysis, technology is expected to be one of the significant factors that will lead to growth in the global endocrine testing market size.
- Aging population increases hormone testing demand: The rise in the aging population worldwide propels the growth of the endocrine testing market since the older generation is equally vulnerable to issues or diseases regarding the endocrine system. Analysis of the market shows that such a trend in demographics opens paths to sustained demand for hormone testing, particularly thyroid, adrenal, and sex hormones. It has been learned from several reports on markets that an aging population tends to propagate growth in the segment of endocrine testing, where the general size of the global market benefits from the importance of age-specific testing solutions for healthcare systems across the world.
- Point-of-care testing reshapes diagnostics: This has been one of those fast-emerging trends, a point-of-care testing trend, which reshapes diagnostic methodologies and allows quicker results directly at health facilities. Major players are targeting the development of POC devices that are convenient and time-saving. As evident from the dynamics of the market, due to this trend, endocrine testing has become more accessible, and market forecast data portrays growth in demand for POC solutions. These are the reasons companies are trying to implement strategies to extend their offerings of POCs, thereby capturing this fast-growing market segment.
- AI and automation enhance efficiency: AI and laboratory automation are widely used in the testing of endocrine diseases these days, promising efficiency and accuracy. Major players are now in the development and integration of AI-enabled diagnostic tools and automated solutions to facilitate processes. SWOT analysis reflects that automation grants competitive advantages through reduced human error and expedited results of tests. According to market forecasts, this trend will shape the key strategies of players, since companies have to invest in technology to be able to compete and meet growing demand.
- Home-based testing gains popularity: An important trend being hailed as a driver in the market is that which is shifting toward home-based endocrine tests. This is attributed to consumer convenience and demand for privacy. Major players are concentrating on the development of self-testing kits regarding hormone levels for maintaining health at home. Market dynamics seem to indicate that this is in tune with the trend of consumer preference toward remote healthcare solutions. Market projections indicate that with increasing demand, manufacturers are likely to focus on strategies involving home-based testing in a bid to increase market share and meet changing customer demands.
- North America, Europe offer growth potential: With a high expenditure on healthcare, North America and Europe have well-established diagnostic infrastructures that are potential markets for endocrine testing. The market overview identifies these regions as key markets, emphasizing preventive health. Companies focusing on expanding their operations in these geographies will capture a sizeable market share. The industry landscape portrays the established healthcare frameworks in North America and Europe as offering ideal opportunities for advanced endocrine testing solutions, thus supporting sustained Endocrine Testing Market growth.
- Emerging markets in Asia-Pacific expand opportunities: With increasing access to healthcare and awareness, especially in the Asia-Pacific regions, growth opportunities remain untapped for endocrine testing in emerging economies. This is supported by Endocrine Testing Market analysis that shows the extended reach of healthcare infrastructure in these regions is driving a surge in demand for advanced diagnostic tools. Report analysis of the industry landscape further indicates that companies entering these emerging markets are likely to realize a competitive advantage and market share capture. By targeting growth opportunities in such regions, strategies pursued align with leading players' global expansion efforts.
- Personalized healthcare drives market growth: The trend in personalized and preventive healthcare, therefore, gives the endocrine testing market significant cause for growth. The snapshot of the Endocrine Testing Market overview indicates that with peoples' tendency to be more proactive in their health monitoring, personalized solutions for hormone testing become increasingly sought after. This presents new opportunities for the companies to capture greater Endocrine Testing Market share by offering differentiated testing solutions. A focus on preventive medicine meets the consumer's demands and this supports growth, especially in light of an industry landscape moving toward more personalized health services.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Endocrine Testing Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Endocrine Testing Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Endocrine Testing Market is expected to register a CAGR of 8.3% from 2023-2031.
The major factors impacting the Endocrine Testing Market are: Rising Prevalence of Endocrine Disorders, Technological Advancements in Diagnostic Testing, and Increasing Geriatric Population
Key future trends in this market are - Growth in hormone therapy, Increased demand for fertility treatments, Rise in thyroid and metabolic disorder testing
Key companies of this market are: Abbott Laboratories, AB Sciex Pte. Ltd, Agilent Technologies, Biomedical Technologies, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, LabCorp, Ortho Clinical Technologies, Quest Technology, Siemens Healthcare.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Endocrine Testing Market - By Test
1.3.2 Endocrine Testing Market - By Technology
1.3.3 Endocrine Testing Market - By End User
1.3.4 Endocrine Testing Market - By Technology
1.3.5 Endocrine Testing Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ENDOCRINE TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ENDOCRINE TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ENDOCRINE TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. ENDOCRINE TESTING - GLOBAL MARKET OVERVIEW
6.2. ENDOCRINE TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ENDOCRINE TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TEST
7.1. OVERVIEW
7.2. TEST MARKET FORECASTS AND ANALYSIS
7.3. THYROID
7.3.1. Overview
7.3.2. Thyroid Market Forecast and Analysis
7.4. INSULIN
7.4.1. Overview
7.4.2. Insulin Market Forecast and Analysis
7.5. FOLLICLE STIMULATING HORMONE
7.5.1. Overview
7.5.2. Follicle Stimulating Hormone Market Forecast and Analysis
7.6. ESTRADIOL
7.6.1. Overview
7.6.2. Estradiol Market Forecast and Analysis
7.7. TESTOSTERONE
7.7.1. Overview
7.7.2. Testosterone Market Forecast and Analysis
7.8. LUTEINIZING HORMONE
7.8.1. Overview
7.8.2. Luteinizing Hormone Market Forecast and Analysis
7.9. PROGESTERONE
7.9.1. Overview
7.9.2. Progesterone Market Forecast and Analysis
7.10. DHEA-S
7.10.1. Overview
7.10.2. DHEA-S Market Forecast and Analysis
7.11. PROLACTIN
7.11.1. Overview
7.11.2. Prolactin Market Forecast and Analysis
7.12. HUMAN CHORIONIC GONADOTROPIN
7.12.1. Overview
7.12.2. Human Chorionic Gonadotropin Market Forecast and Analysis
7.13. CORTISOL AND OTHERS
7.13.1. Overview
7.13.2. Cortisol and Others Market Forecast and Analysis
8. ENDOCRINE TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOASSAY
8.3.1. Overview
8.3.2. Immunoassay Market Forecast and Analysis
8.4. TANDEM MASS SPECTROMETRY
8.4.1. Overview
8.4.2. Tandem Mass Spectrometry Market Forecast and Analysis
8.5. MONOCLONAL AND POLYCLONAL ANTIBODY
8.5.1. Overview
8.5.2. Monoclonal and Polyclonal Antibody Market Forecast and Analysis
8.6. SENSOR TECHNOLOGY
8.6.1. Overview
8.6.2. Sensor Technology Market Forecast and Analysis
8.7. CLINICAL CHEMISTRY AND OTHERS
8.7.1. Overview
8.7.2. Clinical Chemistry and others Market Forecast and Analysis
9. ENDOCRINE TESTING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTIC LABORATORY AND OTHERS
9.4.1. Overview
9.4.2. Diagnostic Laboratory and Others Market Forecast and Analysis
10. ENDOCRINE TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
10.1. OVERVIEW
10.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
10.3. IMMUNOASSAY
10.3.1. Overview
10.3.2. Immunoassay Market Forecast and Analysis
10.4. TANDEM MASS SPECTROMETRY
10.4.1. Overview
10.4.2. Tandem Mass Spectrometry Market Forecast and Analysis
10.5. MONOCLONAL AND POLYCLONAL ANTIBODY
10.5.1. Overview
10.5.2. Monoclonal and Polyclonal Antibody Market Forecast and Analysis
10.6. SENSOR TECHNOLOGY
10.6.1. Overview
10.6.2. Sensor Technology Market Forecast and Analysis
10.7. CLINICAL CHEMISTRY AND OTHERS
10.7.1. Overview
10.7.2. Clinical Chemistry and others Market Forecast and Analysis
11. ENDOCRINE TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Endocrine Testing Market Overview
11.1.2 North America Endocrine Testing Market Forecasts and Analysis
11.1.3 North America Endocrine Testing Market Forecasts and Analysis - By Test
11.1.4 North America Endocrine Testing Market Forecasts and Analysis - By Technology
11.1.5 North America Endocrine Testing Market Forecasts and Analysis - By End User
11.1.6 North America Endocrine Testing Market Forecasts and Analysis - By Technology
11.1.7 North America Endocrine Testing Market Forecasts and Analysis - By Countries
11.1.7.1 United States Endocrine Testing Market
11.1.7.1.1 United States Endocrine Testing Market by Test
11.1.7.1.2 United States Endocrine Testing Market by Technology
11.1.7.1.3 United States Endocrine Testing Market by End User
11.1.7.1.4 United States Endocrine Testing Market by Technology
11.1.7.2 Canada Endocrine Testing Market
11.1.7.2.1 Canada Endocrine Testing Market by Test
11.1.7.2.2 Canada Endocrine Testing Market by Technology
11.1.7.2.3 Canada Endocrine Testing Market by End User
11.1.7.2.4 Canada Endocrine Testing Market by Technology
11.1.7.3 Mexico Endocrine Testing Market
11.1.7.3.1 Mexico Endocrine Testing Market by Test
11.1.7.3.2 Mexico Endocrine Testing Market by Technology
11.1.7.3.3 Mexico Endocrine Testing Market by End User
11.1.7.3.4 Mexico Endocrine Testing Market by Technology
11.1.7.4 US Endocrine Testing Market
11.1.7.4.1 US Endocrine Testing Market by Test
11.1.7.4.2 US Endocrine Testing Market by Technology
11.1.7.4.3 US Endocrine Testing Market by End User
11.1.7.4.4 US Endocrine Testing Market by Technology
11.2. EUROPE
11.2.1 Europe Endocrine Testing Market Overview
11.2.2 Europe Endocrine Testing Market Forecasts and Analysis
11.2.3 Europe Endocrine Testing Market Forecasts and Analysis - By Test
11.2.4 Europe Endocrine Testing Market Forecasts and Analysis - By Technology
11.2.5 Europe Endocrine Testing Market Forecasts and Analysis - By End User
11.2.6 Europe Endocrine Testing Market Forecasts and Analysis - By Technology
11.2.7 Europe Endocrine Testing Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Endocrine Testing Market
11.2.7.1.1 Germany Endocrine Testing Market by Test
11.2.7.1.2 Germany Endocrine Testing Market by Technology
11.2.7.1.3 Germany Endocrine Testing Market by End User
11.2.7.1.4 Germany Endocrine Testing Market by Technology
11.2.7.2 France Endocrine Testing Market
11.2.7.2.1 France Endocrine Testing Market by Test
11.2.7.2.2 France Endocrine Testing Market by Technology
11.2.7.2.3 France Endocrine Testing Market by End User
11.2.7.2.4 France Endocrine Testing Market by Technology
11.2.7.3 Italy Endocrine Testing Market
11.2.7.3.1 Italy Endocrine Testing Market by Test
11.2.7.3.2 Italy Endocrine Testing Market by Technology
11.2.7.3.3 Italy Endocrine Testing Market by End User
11.2.7.3.4 Italy Endocrine Testing Market by Technology
11.2.7.4 Spain Endocrine Testing Market
11.2.7.4.1 Spain Endocrine Testing Market by Test
11.2.7.4.2 Spain Endocrine Testing Market by Technology
11.2.7.4.3 Spain Endocrine Testing Market by End User
11.2.7.4.4 Spain Endocrine Testing Market by Technology
11.2.7.5 United Kingdom Endocrine Testing Market
11.2.7.5.1 United Kingdom Endocrine Testing Market by Test
11.2.7.5.2 United Kingdom Endocrine Testing Market by Technology
11.2.7.5.3 United Kingdom Endocrine Testing Market by End User
11.2.7.5.4 United Kingdom Endocrine Testing Market by Technology
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Endocrine Testing Market Overview
11.3.2 Asia-Pacific Endocrine Testing Market Forecasts and Analysis
11.3.3 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By Test
11.3.4 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By End User
11.3.6 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By Technology
11.3.7 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Endocrine Testing Market
11.3.7.1.1 Australia Endocrine Testing Market by Test
11.3.7.1.2 Australia Endocrine Testing Market by Technology
11.3.7.1.3 Australia Endocrine Testing Market by End User
11.3.7.1.4 Australia Endocrine Testing Market by Technology
11.3.7.2 China Endocrine Testing Market
11.3.7.2.1 China Endocrine Testing Market by Test
11.3.7.2.2 China Endocrine Testing Market by Technology
11.3.7.2.3 China Endocrine Testing Market by End User
11.3.7.2.4 China Endocrine Testing Market by Technology
11.3.7.3 India Endocrine Testing Market
11.3.7.3.1 India Endocrine Testing Market by Test
11.3.7.3.2 India Endocrine Testing Market by Technology
11.3.7.3.3 India Endocrine Testing Market by End User
11.3.7.3.4 India Endocrine Testing Market by Technology
11.3.7.4 Japan Endocrine Testing Market
11.3.7.4.1 Japan Endocrine Testing Market by Test
11.3.7.4.2 Japan Endocrine Testing Market by Technology
11.3.7.4.3 Japan Endocrine Testing Market by End User
11.3.7.4.4 Japan Endocrine Testing Market by Technology
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Endocrine Testing Market Overview
11.4.2 Middle East and Africa Endocrine Testing Market Forecasts and Analysis
11.4.3 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By Test
11.4.4 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By End User
11.4.6 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By Technology
11.4.7 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Endocrine Testing Market
11.4.7.1.1 South Africa Endocrine Testing Market by Test
11.4.7.1.2 South Africa Endocrine Testing Market by Technology
11.4.7.1.3 South Africa Endocrine Testing Market by End User
11.4.7.1.4 South Africa Endocrine Testing Market by Technology
11.4.7.2 Saudi Arabia Endocrine Testing Market
11.4.7.2.1 Saudi Arabia Endocrine Testing Market by Test
11.4.7.2.2 Saudi Arabia Endocrine Testing Market by Technology
11.4.7.2.3 Saudi Arabia Endocrine Testing Market by End User
11.4.7.2.4 Saudi Arabia Endocrine Testing Market by Technology
11.4.7.3 U.A.E Endocrine Testing Market
11.4.7.3.1 U.A.E Endocrine Testing Market by Test
11.4.7.3.2 U.A.E Endocrine Testing Market by Technology
11.4.7.3.3 U.A.E Endocrine Testing Market by End User
11.4.7.3.4 U.A.E Endocrine Testing Market by Technology
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Endocrine Testing Market Overview
11.5.2 South and Central America Endocrine Testing Market Forecasts and Analysis
11.5.3 South and Central America Endocrine Testing Market Forecasts and Analysis - By Test
11.5.4 South and Central America Endocrine Testing Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Endocrine Testing Market Forecasts and Analysis - By End User
11.5.6 South and Central America Endocrine Testing Market Forecasts and Analysis - By Technology
11.5.7 South and Central America Endocrine Testing Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Endocrine Testing Market
11.5.7.1.1 Brazil Endocrine Testing Market by Test
11.5.7.1.2 Brazil Endocrine Testing Market by Technology
11.5.7.1.3 Brazil Endocrine Testing Market by End User
11.5.7.1.4 Brazil Endocrine Testing Market by Technology
11.5.7.2 Argentina Endocrine Testing Market
11.5.7.2.1 Argentina Endocrine Testing Market by Test
11.5.7.2.2 Argentina Endocrine Testing Market by Technology
11.5.7.2.3 Argentina Endocrine Testing Market by End User
11.5.7.2.4 Argentina Endocrine Testing Market by Technology
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ENDOCRINE TESTING MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AB SCIEX PTE. LTD
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. AGILENT TECHNOLOGIES
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BIOMEDICAL TECHNOLOGIES
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DIASORIN S.P.A
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. F.HOFFMANN-LA ROCHE LTD
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. LABCORP
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ORTHO CLINICAL TECHNOLOGIES
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. QUEST TECHNOLOGY
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SIEMENS HEALTHCARE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TER
- Abbott Laboratories
- AB Sciex Pte. Ltd
- Agilent Technologies
- Biomedical Technologies
- DiaSorin S.p.A
- F.Hoffmann-La Roche Ltd
- LabCorp
- Ortho Clinical Technologies
- Quest Technology
- Siemens Healthcare
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For